NCT04598620View on ClinicalTrials.gov

Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

September 19, 2020

Primary Completion Date

October 1, 2021

Study Completion Date

October 1, 2021

Conditions
Covid19Corona Virus Infection
Trial Locations (1)

9000

Aalborg Hospital, Aalborg

All Listed Sponsors
collaborator

Aarhus University Hospital Skejby

OTHER

lead

Inger Lise Gade

OTHER

NCT04598620 - Non-invasive Prognostication of COVID-19 Patients by Use of Biomarkers in Exhaled Breath Condensate | Biotech Hunter | Biotech Hunter